RhumbLine Advisers’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$72.6M Buy
122,486
+735
+0.6% +$366K 0.06% 257
2025
Q4
$59.3M Sell
121,751
-7,078
-5% -$3.3M 0.05% 305
2025
Q3
$54M Sell
128,829
-287
-0.2% -$96.5K 0.04% 339
2025
Q2
$37.1M Buy
129,116
+4,216
+3% +$1.26M 0.03% 461
2025
Q1
$38.5M Sell
124,900
-1,438
-1% -$493K 0.04% 423
2024
Q4
$44.6M Sell
126,338
-2,506
-2% -$921K 0.04% 366
2024
Q3
$46.2M Sell
128,844
-1,998
-2% -$675K 0.04% 360
2024
Q2
$41.7M Sell
130,842
-6,901
-5% -$1.83M 0.04% 374
2024
Q1
$31.6M Sell
137,743
-99
-0.1% -$22.3K 0.03% 487
2023
Q4
$30.3M Sell
137,842
-1,127
-0.8% -$260K 0.03% 478
2023
Q3
$31.4M Sell
138,969
-1,810
-1% -$417K 0.04% 429
2023
Q2
$31.1M Buy
140,779
+6,997
+5% +$1.55M 0.03% 438
2023
Q1
$30M Sell
133,782
-562
-0.4% -$139K 0.04% 434
2022
Q4
$37.4M Buy
134,344
+1,318
+1% +$333K 0.05% 348
2022
Q3
$27.9M Buy
133,026
+3,672
+3% +$821K 0.04% 406
2022
Q2
$30.5M Buy
129,354
+14,487
+13% +$2.95M 0.04% 368
2022
Q1
$20.6M Sell
114,867
-3,840
-3% -$732K 0.03% 568
2021
Q4
$25.6M Buy
118,707
+2,072
+2% +$407K 0.03% 510
2021
Q3
$21.5M Sell
116,635
-4,686
-4% -$923K 0.03% 549
2021
Q2
$21.8M Buy
121,321
+1,083
+0.9% +$206K 0.03% 561
2021
Q1
$20.1M Sell
120,238
-872
-0.7% -$145K 0.03% 576
2020
Q4
$18.4M Buy
121,110
+6,066
+5% +$796K 0.03% 583
2020
Q3
$11.6M Sell
115,044
-2,528
-2% -$277K 0.02% 693
2020
Q2
$14.2M Buy
117,572
+1,890
+2% +$213K 0.02% 600
2020
Q1
$11M Buy
115,682
+9,642
+9% +$916K 0.02% 627
2019
Q4
$9.34M Buy
106,040
+785
+0.7% +$69.1K 0.02% 871
2019
Q3
$8.39M Sell
105,255
-212
-0.2% -$17.1K 0.02% 874
2019
Q2
$8.23M Buy
105,467
+497
+0.5% +$46.5K 0.02% 888
2019
Q1
$12.3M Sell
104,970
-4,138
-4% -$482K 0.02% 657
2018
Q4
$11.9M Buy
109,108
+29,895
+38% +$3.47M 0.03% 615
2018
Q3
$10.1M Sell
79,213
-1,876
-2% -$232K 0.02% 674
2018
Q2
$9.18M Sell
81,089
-1,401
-2% -$154K 0.02% 718
2018
Q1
$9.27M Sell
82,490
-4,000
-5% -$508K 0.02% 698
2017
Q4
$12.8M Sell
86,490
-1,489
-2% -$189K 0.03% 587
2017
Q3
$10.3M Buy
87,979
+7,582
+9% +$968K 0.02% 655
2017
Q2
$10.4M Sell
80,397
-4,455
-5% -$556K 0.02% 620
2017
Q1
$11.5M Buy
84,852
+4,088
+5% +$619K 0.03% 590
2016
Q4
$11.6M Buy
80,764
+4,317
+6% +$551K 0.03% 562
2016
Q3
$9.03M Buy
76,447
+799
+1% +$96K 0.02% 607
2016
Q2
$8.01M Sell
75,648
-3,946
-5% -$440K 0.02% 619
2016
Q1
$8.87M Buy
79,594
+890
+1% +$113K 0.03% 580
2015
Q4
$12.3M Buy
78,704
+443
+0.6% +$64.5K 0.04% 431
2015
Q3
$10.3M Buy
78,261
+2,494
+3% +$400K 0.03% 497
2015
Q2
$13.2M Buy
75,767
+2,599
+4% +$468K 0.04% 431
2015
Q1
$12.6M Buy
73,168
+4,926
+7% +$751K 0.04% 437
2014
Q4
$8.84M Sell
68,242
-80
-0.1% -$10.3K 0.03% 540
2014
Q3
$8.79M Sell
68,322
-2,124
-3% -$219K 0.03% 514
2014
Q2
$6.23M Sell
70,446
-5,185
-7% -$499K 0.02% 691
2014
Q1
$7.11M Sell
75,631
-1,131
-1% -$116K 0.02% 648
2013
Q4
$8.68M Sell
76,762
-6,420
-8% -$579K 0.03% 548
2013
Q3
$6.56M Sell
83,182
-1,403
-2% -$103K 0.02% 678
2013
Q2
$5.57M Buy
+84,585
New +$5.45M 0.02% 724

Other funds holding UTHR